Table 69 HIV patients age 18 and over with CD4 cell count less than 50 who received MAC prophylaxis,a by race/ethnicity, United States, 2004 |
Population group |
Total |
White |
Black |
Hispanic |
Other |
Percent |
SE |
Percent |
SE |
Percent |
SE |
Percent |
SE |
Percent |
SE |
Total |
|
81.8 |
1.2 |
79.1 |
3.0 |
80.9 |
1.6 |
86.7 |
2.5 |
* |
* |
Age |
18-44 |
83.5 |
1.4 |
80.9 |
3.4 |
82.0 |
2.0 |
90.2 |
2.6 |
* |
* |
45 and over |
78.1 |
2.4 |
75.0 |
5.6 |
78.6 |
3.0 |
77.1 |
6.1 |
* |
* |
Gender |
Male |
82.6 |
1.4 |
78.0 |
3.1 |
82.8 |
1.9 |
87.5 |
2.8 |
* |
* |
Female |
79.1 |
2.7 |
* |
* |
76.6 |
3.2 |
82.9 |
5.9 |
* |
* |
Health insurance |
Private |
75.8 |
5.5 |
* |
* |
71.1 |
7.5 |
* |
* |
* |
* |
Medicaid/dual eligible |
83.0 |
1.9 |
76.0 |
6.1 |
82.2 |
2.4 |
88.3 |
3.7 |
* |
* |
Medicare |
79.0 |
2.9 |
84.9 |
5.0 |
77.7 |
4.0 |
* |
* |
* |
* |
Other/uninsured |
86.3 |
2.3 |
85.2 |
4.9 |
85.47 |
3.3 |
90.2 |
3.8 |
* |
* |
a For HIV patients having at least two CD4 tests < 50 during the year.
* Data do not meet the criteria for statistical reliability, data quality, or confidentiality.
Key: MAC: Mycobacterium avium complex; SE: standard error.
Source: HIV Research Network.